Concord Medical Services Files 6-K for Annual Results

TL;DR

Concord Medical Services (CCM) filed its 6-K for annual results on 3/27/24. Check 20-F for details.

AI Summary

Concord Medical Services Holdings Limited filed a Form 6-K on March 27, 2024, to report its annual results. The filing is for the month of March 2024 and is submitted under the Securities Exchange Act of 1934. The company is a foreign private issuer and files annual reports under Form 20-F.

Why It Matters

This filing provides an update on Concord Medical Services' annual performance, which is crucial for investors to assess the company's financial health and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of annual results and does not contain significant new risks or material adverse information.

Key Players & Entities

• Concord Medical Services Holdings Limited (company) — Filer of the 6-K
• 001-34563 (company) — SEC File Number
• Form 20-F (document) — Annual report form
• Form 6-K (document) — Report of Foreign Private Issuer

FAQ

Filing Documents

• tm249939d1_6k.htm (6-K) — 11KB
• 0001104659-24-039692.txt ( ) — 12KB

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s Republic of China (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Concord Healthcare Announces Annual Results on The Stock Exchange of Hong Kong Limited Concord Healthcare Group Co., Ltd. (“Concord Healthcare”), a subsidiary of Concord Medical Services Holdings Limited (the “Company”) (NYSE: CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong Limited (the “HKSE”) under the stock code 2453.HK, announced its annual results for the year ended December 31, 2023 on March 27, 2024. The Company previously announced the listing of Concord Healthcare’s H shares on the HKSE on January 9, 2024. The information related to the announcement of Concord Healthcare’s annual results on the HKSE is accessible through the HKSE’s website at www.hkexnews.hk . SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CONCORD MEDICAL SERVICES HOLDINGS LIMITED By: /s/ Jianyu Yang Name: Jianyu Yang Title: Chairman and Chief Executive Officer Date: March 27, 2024

View Full Filing

View this 6-K filing on SEC EDGAR